Rheumatoid Arthritis Associated With Glaucoma Development: JAMA
- byDoctor News Daily Team
 - 11 July, 2025
 - 0 Comments
 - 0 Mins
 
                            
                                    South Korea: A recent study in JAMA Network Open suggests that rheumatoid arthritis (RA) is associated with a higher risk of primary open-angle glaucoma (POAG) development. This was especially seen within 2 years after diagnosis or among patients aged 75 years or older.
"The possibility of an immune-mediated common pathophysiological pathway invites further investigation," Seung Hoon Kim, Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea, and colleagues wrote in their study.
The evidence on the association between autoimmunity and neurodegeneration in glaucoma (beyond intraocular pressure-mediated damage) is emerging. However, there is not much evidence on the connection between rheumatoid arthritis (RA), the most common autoimmune disease, with the risk of developing primary open-angle glaucoma (POAG).
Against the above background, the authors aimed to investigate if RA is associated with an increased risk of POAG among Korean older adults in a nationwide propensity-matched cohort study.
The study was conducted using data from the Korean National Health Insurance Service-Senior cohort from 2002 to 2013. Data analysis was performed from November 2020 to July 2021.
The development of POAG was the primary outcome. The cumulative incidence of POAG was calculated using the Kaplan-Meier method, and the incidence rate of POAG was estimated using Poisson regression. The associations between RA and risk of POAG were investigated using a Cox proportional hazards regression model.
Among 10 245 participants, 7490 (73.1%) were women, and the mean age was 67.70 years.
Based on the study, the researchers reported the following findings:
A total of 2049 patients with incident seropositive RA and 8196 time-dependent, propensity score-matched, risk-set controls were included.
POAG was developed in 86 of 2049 patients with RA and 254 of 8196 matched controls.
The cumulative incidence of POAG was higher in the RA cohort than in the matched controls.
In the RA cohort, the incidence rate of POAG was 981.8 cases per 100 000 person-years, whereas, in the matched controls, the incidence rate was 679.5 cases per 100 000 person-years.
Patients with RA were more likely to develop POAG than the matched controls (hazard ratio [HR], 1.44).
Increased POAG risk in the RA cohort was predominantly observed 2 years into the follow-up period (HR, 1.83) and in those aged 75 years or older (HR, 2.12).
"Findings indicate that RA is associated with a higher risk of POAG development, especially within 2 years after diagnosis or among patients aged 75 years or older," wrote the authors. "A common pathophysiological pathway may be present between RA and POAG that is possibly immune-mediated, and the nature of this association warrants further investigation."
Reference:
Kim SH, Jeong SH, Kim H, Park E, Jang S. Development of Open-Angle Glaucoma in Adults With Seropositive Rheumatoid Arthritis in Korea. JAMA Netw Open. 2022;5(3):e223345. doi:10.1001/jamanetworkopen.2022.3345
KEYWORDS: JAMA, glaucoma, rheumatoid arthritis, primary open angle glaucoma, Seung Hoon Kim, autoimmune disease, immune mediated, older adults
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Tags:
Recent News
What Your Neck Size Says About Your Heart Health?...
- 04 November, 2025
 
EVOQUE TTVR Delivers Promising Real-World Results:...
- 04 November, 2025
 
Influenza Vaccination Reduces Mortality and Readmi...
- 04 November, 2025
 
Can Technology Make Kids Healthier? New Research S...
- 04 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!